Last Updated on December 31, 2023 by The Health Master
Sun Pharmaceutical Industries announced that the New Drug Application (NDA) for Tildrakizumab injection under the brand name Ilumetri has been approved by the National Medical Products Administration of the People’s Republic of China (NMPA).
Tildrakizumab injection is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
In June 2019, Sun Pharma out-licensed tildrakizumab to a subsidiary of China Medical System Holdings Limited (CMS), for development, regulatory filings and commercialisation of the product in Greater China.
According to CMS, the results of the extended study of Phase III clinical trial in China demonstrated that the primary efficacy assessment indicator PASI 75 response rate continued to increase over the treatment time.
The PASI 75 response rate reached a high level after 28 weeks of treatment with ILUMETRI and maintained at 91.3 per cent at week 52, and Tildrakizumab injection (Ilumetri) showed good long-term safety and tolerance.
Tildrakizumab Injection has also been approved for marketing in the US, EU, Japan, UK, Switzerland, Canada, Australia, Hong Kong and other countries/regions under the brands of ILUMYA and ILUMETRI in different geographies.
Delhi High Court grants Centre 6 weeks to finalize Rules for E-Pharmacies
DPCO 2013: Form 2, 4 & 5 amended to add details including GST rate
Line clearance and maintenance in manufacturing: A comprehensive guide
18 held for Sex Determination in Telangana
Govt explores Trade Margin Rationalisation in Pharma and Medical Devices Industry
IDMA urges NPPA to exempt Low-Cost Formulations from Price Control
Medical device packs will have to display key information
IDMA proposes additional cost allowance for QR Code implementation
Difference between Validation and Calibration in the Pharma Industry
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon: